State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Auto-generated profile, based on publicly available information
Weizhi He
State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Figure S1.Flow cytometry analysis of IL-22RA1 expression among PDAC; Figure S2. The correlation analyses between IL-22RA1 and CSCs Figure S3. IL-22RA1hi pancreatic cancer cells have CSCs properties Figure S4. IL-22RA1hi pancreatic cancer cells express higher EMT markers FigureS5. IL-22 promotes stemness of pancreatic cancer cells FigureS6. IL-6 activates STAT3, but unable to promote stemness of PDACs Figure S7. Dot1L is not involved in IL-22 induced stemness of PDACs Table S1. Quantitative real-time PCR and ChIP primers TableS2&3. The co-relationship between IL-22RA1 expression and PDAC patients characteristics
Figure S1.Flow cytometry analysis of IL-22RA1 expression among PDAC; Figure S2. The correlation analyses between IL-22RA1 and CSCs Figure S3. IL-22RA1hi pancreatic cancer cells have CSCs properties Figure S4. IL-22RA1hi pancreatic cancer cells express higher EMT markers FigureS5. IL-22 promotes stemness of pancreatic cancer cells FigureS6. IL-6 activates STAT3, but unable to promote stemness of PDACs Figure S7. Dot1L is not involved in IL-22 induced stemness of PDACs Table S1. Quantitative real-time PCR and ChIP primers TableS2&3. The co-relationship between IL-22RA1 expression and PDAC patients characteristics